RxDoctor Payments Data

Monique Spillman, MD

Gynecologic Oncology · Little Rock, ARNPI 1164431052

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (53.3%), travel and lodging and gifts — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 84.8% of it on its own, with 5 other manufacturers making up the rest. 2024 is the largest year on record at $1,511, more than ten times the $99 reported in 2019.

$1,828in general payments, 2019–2025

Across 10 payments — averaging $182.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$2K
  • Myriad Genetic Laboratories, Inc.$109
  • Biogen$99
  • Innovation Technologies Inc$37
  • Conmed Corporation$29
  • Clovis Oncology, Inc.$3
$25,243in research payments, 2019–2025

Across 6 payments — averaging $4207.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$25K

What the payments were for

  • Travel & lodging$83546%
  • Food & beverage$97553%
  • Education$30%
  • Gifts$151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few gynecologic oncology providers in Arkansasto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$28,525
Medicare patients
83
Services billed
259

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gynecologic oncology in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →